Alice C Harnden, Owen A Davis, Gary M Box, Angela Hayes, Louise D Johnson, Alan T Henley, Alexis K de Haven Brandon, Melanie Valenti, Kwai-Ming J Cheung, Alfie Brennan, Rosemary Huckvale, Olivier A Pierrat, Rachel Talbot, Michael D Bright, Hafize Aysin Akpinar, Daniel S J Miller, Dalia Tarantino, Sharon Gowan, Selby de Klerk, Peter Craig McAndrew, Yann-Vaï Le Bihan, Mirco Meniconi, Rosemary Burke, Vladimir Kirkin, Rob L M van Montfort, Florence I Raynaud, Olivia W Rossanese, Benjamin R Bellenie, Swen Hoelder
B-cell lymphoma 6 (BCL6) is a transcriptional repressor and oncogenic driver of diffuse large B-cell lymphoma (DLBCL). Here, we report the optimization of our previously reported tricyclic quinolinone series for the inhibition of BCL6. We sought to improve the cellular potency and in vivo exposure of the non-degrading isomer, CCT373567 , of our recently published degrader, CCT373566 . The major limitation of our inhibitors was their high topological polar surface areas (TPSA), leading to increased efflux ratios...
April 7, 2023: Journal of Medicinal Chemistry